Our analysts have finally finished the report we’ve all been waiting for.

The Top Five Ai Stocks that are part of the new AI Gold Rush happening in the world right now.

5 years from now, you just might wish you’d gotten in early on these stocks.

Click here to get the names of all 5 companies

ATXI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.35%

Insider Buying (Last 12 Months): $552,301.20

Insider Selling (Last 12 Months): $0.00

Avenue Therapeutics Insider Trading History Chart

Avenue Therapeutics Share Price & Price History

^$0.71

▲ +0.04 (6.00%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

Public Service Announcement: New National Emergency Incoming

From Porter and Company | Ad

Americans urged to share this new documentary with their friends and family before this looming event triggers a new national crisis…

Watch the most eye-opening film of the year for free

Avenue Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/8/2023	Fortress Biotech, Inc.	Major Shareholder	Buy	418,410	$0.72	$301,255.20	1,032,390
9/8/2023	Lindsay A Md Rosenwald	Director	Buy	348,675	$0.72	$251,046.00	354,318
9/15/2021	Joseph Walter Vazzano	CFO	Sell	7,160	$1.62	$11,599.20	65,252
5/6/2021	Neil Herskowitz	Director	Buy	2,500	$3.99	$9,975.00
5/6/2021	Neil Herskowitz	Director	Buy	2,500	$3.99	$9,975.00

Better Than Oil Stocks

From Oxford Club | Ad

The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.

CLICK HERE TO FIND OUT MORE

SEC Filings (Institutional Ownership Changes) for Avenue Therapeutics (NASDAQ:ATXI)

9.38% of Avenue Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Avenue Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/11/2023	Geode Capital Management LLC	52,571	$60K	0.0%	+359.9%	0.665%
5/16/2023	Sabby Management LLC	279,898	$0.33M	0.3%	+6.0%	3.534%
5/16/2023	State Street Corp	30,593	$36K	0.0%	N/A	0.386%
2/15/2023	Virtu Financial LLC	32,570	$38K	0.0%	N/A	0.641%
11/15/2022	Two Sigma Investments LP	14,342	$0.15M	0.0%	N/A	0.972%
11/15/2022	Citadel Advisors LLC	35,865	$0.36M	0.0%	N/A	2.423%
8/13/2022	Renaissance Technologies LLC	124,400	$34K	0.0%	N/A	0.572%
5/17/2022	Virtu Financial LLC	58,004	$28K	0.0%	N/A	0.267%
1/28/2022	National Asset Management Inc.	71,338	$65K	0.0%	-20.1%	0.376%
11/16/2021	National Asset Management Inc.	89,237	$0.13M	0.0%	-29.2%	0.531%
10/19/2021	Kestra Advisory Services LLC	22,500	$34K	0.0%	N/A	0.134%
9/17/2021	Virtu Financial LLC	26,373	$66K	0.0%	N/A	0.157%
9/3/2021	Parametric Portfolio Associates LLC	10,554	$26K	0.0%	-59.2%	0.063%
8/16/2021	Occudo Quantitative Strategies LP	14,398	$36K	0.0%	N/A	0.086%
8/13/2021	Renaissance Technologies LLC	78,314	$0.20M	0.0%	N/A	0.468%
8/13/2021	Northern Trust Corp	13,767	$35K	0.0%	-82.1%	0.082%
8/13/2021	Geode Capital Management LLC	79,556	$0.20M	0.0%	-40.0%	0.475%
8/13/2021	Vanguard Group Inc.	449,982	$1.13M	0.0%	-35.5%	2.687%
8/12/2021	XTX Topco Ltd	10,864	$27K	0.0%	N/A	0.065%
8/12/2021	Advisory Services Network LLC	35,121	$88K	0.0%	N/A	0.210%
8/12/2021	Ergoteles LLC	30,400	$76K	0.0%	N/A	0.182%
8/10/2021	National Asset Management Inc.	126,037	$0.32M	0.0%	-26.1%	0.753%
5/20/2021	Axiom Investment Management LLC	10,000	$60K	0.0%	N/A	0.060%
5/19/2021	Squarepoint Ops LLC	11,668	$71K	0.0%	N/A	0.070%
5/17/2021	Goldman Sachs Group Inc.	17,319	$0.11M	0.0%	N/A	0.103%
5/13/2021	Trexquant Investment LP	13,874	$84K	0.0%	N/A	0.083%
5/13/2021	Axiom Investment Management LLC	10,000	$60K	0.0%	N/A	0.060%
5/13/2021	Barclays PLC	5,568	$34K	0.0%	+159.0%	0.033%
5/12/2021	Northern Trust Corp	77,049	$0.47M	0.0%	-6.8%	0.460%
5/12/2021	Geode Capital Management LLC	132,594	$0.80M	0.0%	+5.9%	0.792%
2/24/2021	Virtu Financial LLC	17,469	$0.10M	0.0%	N/A	0.104%
2/19/2021	JPMorgan Chase & Co.	17,102	$0.10M	0.0%	+260.2%	0.102%
2/17/2021	Jane Street Group LLC	13,288	$79K	0.0%	N/A	0.079%
2/11/2021	Northern Trust Corp	82,691	$0.49M	0.0%	+2.1%	0.494%
2/9/2021	Wells Fargo & Company MN	16,406	$98K	0.0%	-13.2%	0.098%
2/5/2021	BlackRock Inc.	361,486	$2.15M	0.0%	+5.5%	2.158%
2/4/2021	National Asset Management Inc.	167,787	$1M	0.1%	+15.0%	1.002%
11/13/2020	Morgan Stanley	22,706	$0.25M	0.0%	+270.9%	0.136%
11/10/2020	State Street Corp	73,316	$0.79M	0.0%	+9.5%	0.438%
11/9/2020	National Asset Management Inc.	145,887	$1.58M	0.1%	+42.7%	0.871%
11/6/2020	BlackRock Inc.	342,742	$3.71M	0.0%	+7.4%	2.052%
10/20/2020	Nisa Investment Advisors LLC	19,069	$0.21M	0.0%	N/A	0.114%
8/25/2020	Nuveen Asset Management LLC	32,114	$0.35M	0.0%	N/A	0.192%
8/20/2020	Charles Schwab Investment Management Inc.	14,314	$0.16M	0.0%	N/A	0.086%
8/17/2020	Jane Street Group LLC	14,010	$0.15M	0.0%	N/A	0.084%
8/14/2020	Bank of America Corp DE	2,694	$29K	0.0%	-62.0%	0.016%
8/12/2020	American International Group Inc.	4,075	$44K	0.0%	N/A	0.024%
8/12/2020	Bank of New York Mellon Corp	15,032	$0.16M	0.0%	N/A	0.090%
8/7/2020	New York State Common Retirement Fund	9,000	$97K	0.0%	N/A	0.054%
7/31/2020	National Asset Management Inc.	102,200	$1.10M	0.1%	+6.5%	0.613%
7/31/2020	UBS Group AG	6,328	$68K	0.0%	+216.4%	0.038%
7/31/2020	Mackay Shields LLC	25,300	$0.27M	0.0%	N/A	0.152%
5/18/2020	Advisor Group Holdings Inc.	33,745	$0.30M	0.0%	N/A	0.202%
5/15/2020	Squarepoint Ops LLC	19,410	$0.17M	0.0%	N/A	0.116%
5/15/2020	Morgan Stanley	4,691	$42K	0.0%	+47.3%	0.028%
5/14/2020	Geode Capital Management LLC	70,115	$0.63M	0.0%	+3.2%	0.420%
5/9/2020	National Asset Management Inc.	96,000	$0.86M	0.1%	+25.9%	0.576%
5/1/2020	BlackRock Inc.	47,057	$0.42M	0.0%	+7.9%	0.282%
2/13/2020	Renaissance Technologies LLC	12,553	$0.12M	0.0%	N/A	0.075%
2/10/2020	National Asset Management Inc.	76,250	$0.73M	0.1%	+3.4%	0.458%
11/27/2019	Squarepoint Ops LLC	12,726	$76K	0.0%	N/A	0.076%
8/13/2019	BlackRock Inc.	39,933	$0.25M	0.0%	+135.7%	0.241%
8/5/2019	National Asset Management Inc.	64,750	$0.41M	0.0%	+9.3%	0.391%
5/8/2019	National Asset Management Inc.	59,250	$0.28M	0.0%	-10.6%	0.358%
5/7/2019	Spark Investment Management LLC	30,500	$0.14M	0.0%	N/A	0.184%
2/14/2019	Opaleye Management Inc.	496,000	$2.68M	1.0%	N/A	4.649%
2/12/2019	Northern Trust Corp	14,568	$79K	0.0%	N/A	0.137%
2/8/2019	National Asset Management Inc.	66,250	$0.36M	0.1%	+4.7%	0.621%

Data available starting January 2016

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.

Today's Range

Now: $0.71

$0.65

$0.71

50 Day Range

MA: $0.88

$0.56

$1.12

52 Week Range

Now: $0.71

$0.54

$16.65

Volume

24,629 shs

Average Volume

76,791 shs

Market Capitalization

$5.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Avenue Therapeutics?: Avenue Therapeutics' top insider shareholders include:
Fortress Biotech, Inc (Major Shareholder)
Lindsay A Md Rosenwald (Director)
Invagen Pharmaceuticals, Inc (Major Shareholder)
Learn More about top insider investors at Avenue Therapeutics.

It’s finally here…

From ProTrading Research | Ad